WAYNE, Pa.--(BUSINESS WIRE)--Aug. 2, 2006--Covalent Group, Inc. (Nasdaq: CVGR) (“Covalent”), a leader in the design and management of complex clinical trials and patient disease registries for the pharmaceutical, biotechnology and medical device industries, today announced that it will issue its financial results for the second quarter ended June 30, 2006 on August 8, 2006 after market close, with an accompanying conference call on Wednesday, August 9, 2006 at 9:00 A.M. ET.
